Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionMutual Advisors, LLC
Latest Disclosed Ownership21,407 shares
Latest Disclosed Value $ 2,983,457
Mutual Advisors, LLC reports 3.45% decrease in ownership of GILD / Gilead Sciences, Inc.

On May 1, 2026 - Mutual Advisors, LLC filed a 13F-HR form disclosing ownership of 21,407 shares of Gilead Sciences, Inc. (CH:GILD) valued at $2,983,457 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 22,172 shares of Gilead Sciences, Inc.. This represents a change in shares of -3.45% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F GILEAD SCIENCES COM 375558103 21,407 -765 -3.45 2,983 9.63 0.0638
2026-02-02 2025-12-31 13F GILEAD SCIENCES COM 375558103 22,172 -806 -3.51 2,721 -1.91 0.0583
2025-11-04 2025-09-30 13F GILEAD SCIENCES COM 375558103 22,978 1,750 8.24 2,774 12.49 0.0611
2025-07-28 2025-06-30 13F GILEAD SCIENCES COM 375558103 21,228 3,072 16.92 2,467 31.66 0.0616
2025-04-28 2025-03-31 13F GILEAD SCIENCES COM 375558103 18,156 -3,917 -17.75 1,873 -7.41 0.0536
2025-01-17 2024-12-31 13F GILEAD SCIENCES COM 375558103 22,073 -1,005 -4.35 2,023 -1.22 0.0586
2024-10-25 2024-09-30 13F GILEAD SCIENCES COM 375558103 23,078 -27,538 -54.41 2,049 -47.94 0.0599
2024-07-30 2024-06-30 13F GILEAD SCIENCES COM 375558103 50,616 16,056 46.46 3,934 55.43 0.1188
2024-05-02 2024-03-31 13F GILEAD SCIENCES COM 375558103 34,560 6,654 23.84 2,532 11.99 0.0812
2024-01-12 2023-12-31 13F GILEAD SCIENCES COM 375558103 27,906 702 2.58 2,261 10.89 0.0787
2023-11-13 2023-09-30 13F GILEAD SCIENCES COM 375558103 27,204 1,064 4.07 2,039 1.19 0.0795
2023-07-31 2023-06-30 13F GILEAD SCIENCES COM 375558103 26,140 -181 -0.69 2,015 -7.74 0.0765
2023-04-11 2023-03-31 13F GILEAD SCIENCES COM 375558103 26,321 1,828 7.46 2,184 3.85 0.0896
2023-01-12 2022-12-31 13F GILEAD SCIENCES COM 375558103 24,493 -1,280 -4.97 2,103 32.20 0.0941
2022-11-03 2022-09-30 13F GILEAD SCIENCES COM 375558103 25,773 2,304 9.82 1,590 9.58 0.0818
2022-08-15 2022-06-30 13F GILEAD SCIENCES COM 375558103 23,469 2,449 11.65 1,451 16.08 0.0961
2022-05-09 2022-03-31 13F GILEAD SCIENCES COM 375558103 21,020 179 0.86 1,250 -17.38 0.0700
2022-02-14 2021-12-31 13F GILEAD SCIENCES COM 375558103 20,841 1,753 9.18 1,513 13.50 0.0801
2021-11-15 2021-09-30 13F GILEAD SCIENCES COM 375558103 19,088 762 4.16 1,333 5.63 0.0789
2021-08-12 2021-06-30 13F GILEAD SCIENCES COM 375558103 18,326 -1,819 -9.03 1,262 -3.07 0.0748
2021-05-13 2021-03-31 13F GILEAD SCIENCES COM 375558103 20,145 -6,427 -24.19 1,302 -15.89 0.0891
2021-02-11 2020-12-31 13F GILEAD SCIENCES COM 375558103 26,572 2,685 11.24 1,548 2.58 0.1150
2020-11-13 2020-09-30 13F GILEAD SCIENCES COM 375558103 23,887 3,446 16.86 1,509 -4.07 0.1308
2020-08-05 2020-06-30 13F GILEAD SCIENCES COM 375558103 20,441 4,065 24.82 1,573 28.51 0.1546
2020-05-13 2020-03-31 13F GILEAD SCIENCES COM 375558103 16,376 4,352 36.19 1,224 56.72 0.1661
2020-02-11 2019-12-31 13F GILEAD SCIENCES COM 375558103 12,024 -235 -1.92 781 0.51 0.0831
2019-11-01 2019-09-30 13F GILEAD SCIENCES COM 375558103 12,259 -4,390 -26.37 777 -30.93 0.1026
2019-08-15 2019-06-30 13F GILEAD SCIENCES COM 375558103 16,649 5,876 54.54 1,125 60.71 0.1462
2019-05-15 2019-03-31 13F GILEAD SCIENCES COM 375558103 10,773 1,535 16.62 700 21.11 0.1036
2019-02-15 2018-12-31 13F GILEAD SCIENCES COM 375558103 9,238 62 0.68 578 -18.36 0.1139
2018-11-15 2018-09-30 13F GILEAD SCIENCES COM 375558103 9,176 -1,077 -10.50 708 -2.48 0.1075
2018-08-15 2018-06-30 13F GILEAD SCIENCES COM 375558103 10,253 863 9.19 726 2.54 0.1655
2018-05-11 2018-03-31 13F GILEAD SCIENCES COM 375558103 9,390 9,390 708 0.1794
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.